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During childhood, our brain is exposed to a variety of environmental inputs that
can sculpt synaptic connections and neuronal circuits, with subsequent influence on
behavior and learning processes. Critical periods of neurodevelopment are windows
of opportunity in which the neuronal circuits are extremely plastic and can be easily
subjected to remodeling in response to experience. However, the brain is also more
susceptible to aberrant stimuli that might lead to altered developmental trajectories.
Intriguingly, postnatal brain development is paralleled by the maturation of the gut
microbiota: the ecosystem of symbionts populating our gastro-intestinal tract. Recent
discoveries have started to unveil an unexpected link between the gut microbiome
and neurophysiological processes. Indeed, the commensal bacteria seem to be able
to influence host behavioral outcome and neurochemistry through mechanisms which
remain poorly understood. Remarkably, the efficacy of the gut flora action appears
to be dependent on the timing during postnatal life at which the host gut microbes’
signals reaches the brain, suggesting the fascinating possibility of critical periods for
this microbiota-driven shaping of host neuronal functions and behavior. Therefore, to
understand the importance of the intestinal ecosystem’s impact on neuronal circuits
functions and plasticity during development and the discovery of the involved molecular
mechanisms, will pave the way to identify new and, hopefully, powerful microbiota-
based therapeutic interventions for the treatment of neurodevelopmental and psychiatric
diseases.
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INTRODUCTION
The development of our brain is a complicated process starting during the third week of gestation
and protracting after birth, through late adolescence. Part of this process is genetically encoded,
however experience and environmental stimuli play a fundamental role in refining neuronal
circuits (Stiles and Jernigan, 2010). Indeed, during the postnatal period there is a remarkable
remodeling of cortical and subcortical structures. In particular, the neuronal circuits belonging to
sensory systems encounter an important experience-dependent reshaping.
The brain circuitry is particularly plastic to environmental inputs during preferred windows of
opportunity called sensitive periods (Berardi et al., 2000). Furthermore, critical periods are special
sensory periods, in which the influence of experience results in irreversible brain changes (Knudsen,
2004). Critical periods have been demonstrated for many species, from Drosophila to rodents and
humans and for different functions. Interestingly, the opening of some specific critical periods
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in mice coincides with weaning. For example, the critical period
for ocular dominance plasticity opens at around P21–23 in
mice that perfectly matches with the passage from breast milk
to a solid diet. Remarkably, it has been demonstrated that in
humans the cessation of breast-feeding is one of the major
determinants for the assembly of an adult microbiome (Bäckhed
et al., 2015) and that diet can rapidly alter the composition
of commensal bacteria (David et al., 2014). In the last decade,
the gut microflora has raised the interest of the scientific
community and many studies have begun to investigate its role
on different aspects of host physiology. The gut microbiota has
been implicated in the development of the host immune system
and in shaping its responses during infectious diseases (Round
and Mazmanian, 2009; Brestoff and Artis, 2013). Moreover,
commensal bacteria are instrumental in the control of host
energy metabolism and metabolic homeostasis (Tremaroli and
Bäckhed, 2012).
Recently the gut microbiota has been involved in behavioral
modulation in both rodents and humans (Foster and McVey
Neufeld, 2013), suggesting the intriguing possibility of the
microbiota’s influence on brain development and function. So
far, the majority of studies have focused on the impact of
microbes on the adult central nervous system (CNS). However,
some evidence seems to indicate that the microbiota might also
be involved in the development of neuronal circuits, and that a
healthymicrobiome early in lifemight play a key role for a correct
neurodevelopment (Borre et al., 2014). As stated, breast-feeding
cessation is important for microbiomematurity, while during the
same period the brain faces a dramatic remodeling at circuit and
synaptic levels. Therefore, the microbiota may somehow affect
and contribute to the process of neuronal circuitry refinement
during postnatal development.
This review article will focus principally on studies
investigating the crosstalk between the brain and gut
microbiome, and how the microbiota seems to affect
neuronal function and consequently, the behaviors of the
host. Finally, recent findings linking the commensal bacteria to
neurodevelopmental disorders will be discussed.
GUT MICROBIOTA MATURATION
Our body has a longstanding partnership with a myriad of
microorganisms, such as bacteria, viruses, protozoa, archaea,
fungi, that constitute the so-called microbiota (Sekirov et al.,
2010). These symbionts colonize all the body surfaces that
are in contact with the external environment from birth and
arguably in utero, establishing a lifelong relationship with
their host. Bacteria are the best studied and they seem to
be particularly enriched in the gastrointestinal (GI) tract. The
gut microbiota comprises trillions of bacteria, characterized by
approximately 1000 species and outnumber the genes present in
the human genome (Ley et al., 2006; Qin et al., 2010). Indeed the
intestinal microbiome has been defined as a ‘‘forgotten organ’’
(O’Hara and Shanahan, 2006). The gut ecosystem is dominated
by two bacterial phylotypes: Firmicutes and Bacteriodites,
and as established by metagenomic sequencing, besides inter-
individual variability, the core gut microbiota and microbiome
are shared in humans (Qin et al., 2010). The intestinal bacteria
behave like a factory and produce fundamental molecules for
many host biological processes, such as vitamins, short chain
fatty acids (SCFA: propionate, acetate and butyrate), amino
acids and their derivatives and, interestingly, neurotransmitters.
Moreover, they participate in the metabolism of choline,
bile acids, polyamine and various lipids (Nicholson et al.,
2012).
Colonization of the human GI tract begins at birth. In fact,
the fetus was thought to be completely sterile until few years
ago when provocative studies demonstrated the presence of
bacteria in the placenta and amniotic fluid (Jiménez et al.,
2008; Aagaard et al., 2014; Collado et al., 2016). During vaginal
delivery, the baby is exposed to microbes mainly belonging
to the mother’s vaginal tract and feces; although the bacteria
present in the external milieu, such as the hospital in developed
countries, also contribute to the initial colonization of the
babies’ intestine. C-section strongly influences the neonates’
microbiota that resembles predominantly the one of the mother’s
skin (Matamoros et al., 2013). Thus, the mode of delivery, the
type of feeding (breast or formula milk), the mother’s diet,
the environment and the use of antibiotics significantly impact
the composition of the neonatal gut microbiota and affects its
maturation later in life.
The passage from a milk-based diet to solid food is
extremely important in the maturation of the gut flora
(Jiménez et al., 2008; Aagaard et al., 2014; Collado et al.,
2016) and in humans, the first 3 years of life seems to be
critical for the assembly of the commensals ecosystem. At
the same time, intense synaptogenesis occurs in the brain
(Tau and Peterson, 2010). Notably, the refinement of neuronal
circuits protracts during adolescence, in which a dramatic
synaptic pruning takes place, and during adulthood, when,
although not at the same extent, some synaptic rewiring is
still present (Petanjek et al., 2011). In parallel, the microbiota
evolves from childhood/adolescence, characterized by less
diversity between species (Agans et al., 2011), to adult age. In
adulthood, the gut microbial ecosystem reaches its maturity,
becomes more diverse and stable overtime and more resistant
to perturbation (i.e., antibiotic use, dietary changes, stress;
Rajili´c-Stojanovi´c et al., 2013). It is important to note that
postnatal neurodevelopment and gut microbiota evolution
co-occur, suggesting the intriguing possibility of a bidirectional
influence between brain and commensal bacteria on each other’s
maturation.
THE GUT MICROBIOTA SCULPTS BRAIN
FUNCTION AND BEHAVIOR
Can postnatal microbioal colonization act and have a long-lasting
effect on host brain physiology and plasticity? A ground-
breaking study from 2004 paved the way to the new concept
of gut microbiota impact on brain function and behavior.
Sudo et al. (2004) demonstrated that germ free (GF) mice
(completely sterile animals that have never had contact with any
microorganism) displayed an exaggerated stress response with
respect to specific pathogen free (SPF) mice, animals raised with
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a normal gut flora. The behavioral phenotype was accompanied
by decreased expression of cortical and hippocampal brain
derived neurotrophic factor (BDNF), a neurotrophin involved in
neuronal survival, differentiation, growth, and synaptic plasticity
(Park and Poo, 2013). The oral administration to GF mice of
a single strain of bacterium, Bifidobacterium infantis, rescued
the HPA stress response. Intriguingly, the fecal transplant of
SPF mice microbiome to GF mice at an early developmental
stage successfully restored the stress response to basal levels,
although the same procedure was not efficacious at later age
(Sudo et al., 2004). Similarly, reduced anxiety-like behavior and
increased locomotor activity in GF mice could be reverted by
conventionalization with SPF microbiota only in young but
not in adult mice, suggesting the presence of a period of
opportunity for the action of the gut microbes on neuronal
circuits function and plasticity. Remarkably, the hippocampus,
frontal cortex and striatum of GF mice had dramatic differences
in gene expressionwith respect to SPF.Moreover, synaptophysin,
a protein important for synaptic vesicles endocytosis and
synaptogenesis (Tarsa and Goda, 2002; Kwon and Chapman,
2011), and PSD95, involved in excitatory synaptic maturation
and plasticity (El-Husseini et al., 2000; Béïque and Andrade,
2003), were reduced in the striatum of GF mice (Diaz Heijtz
et al., 2011), indicating that alteration in synaptic plasticity
could be linked to the absence of the intestinal commensals.
Clarke et al., found that the gut microbiome influences the
development of the hippocampal serotonergic system. Indeed,
serotonin levels in the hippocampus of GF mice were increased
and correlated with reduced anxiety, although no direct link
was demonstrated between the neurotransmitter change and
the behavioral phenotype. Post-weaning colonization was not
able to restore the hippocampal neurochemical differences with
respect to the conventionalized mice, however, it could revert the
altered anxiety-like behavior (Clarke et al., 2013). Modifications
in plasticity related genes were also noticed in the amygdala
of GF mice, in which a significant down-regulation of the
NR2B subunit of the NMDA receptor, important for synaptic
plasticity and memory process, was observed and paralleled by
reduced anxiety-like behavior (Neufeld et al., 2011). Remarkably,
the total absence of microbes in GF mice was accompanied
by an enlargement in the amygdala and hippocampal volume,
notwithstanding the whole brain volume was the same.
Furthermore, area-specific alteration in dendritic spines density
and morphology, and dendrites’ length were reported. The
structural modifications might correlate with the behavioral
profile of GF animals, however no causal evidence has been
demonstrated (Luczynski et al., 2016). Moreover, the analysis
was performed only in adult mice leaving an open interrogative
about when early in life these morphological changes occur
and how they could affect developmental trajectories. Antibiotic
treatment of SPF rodents from weaning, in order to ablate the
intestinal commensals, had a strong impact on brain chemistry
and behavioral outcomes resulting in anxiolytic effects, memory
impairments and deficit in the social transmission of food
preference test (Desbonnet et al., 2015). This study emphasizes
the importance of the microbial ecosystem influence on neuronal
physiology during crucial periods of development such as the
post-weaning, which is comparable to adolescence in humans.
Even in adult mice, a short-term broad-spectrum antibiotic
administration could decrease anxiety and up-regulate BDNF
expression in the hippocampus (Bercik et al., 2011). It is
worth noting that the depletion of the gut microbiota, either
through antimicrobial treatment or GF conditions, results in
anxiolytic outcomes apparently in conflict with the increase
in stress reactivity of GF mice (Sudo et al., 2004; Clarke
et al., 2013). It is difficult to explain the discrepancy, especially
considering the complexity of the experimental designs in the
different studies; however this discordance features the possible
intricate and not yet unveiled effects of the microbial community
or individual bacteria on the host brain physiology during
development and adulthood, opening challenging questions for
the future.
As highlighted, neuroplasticity is a complicated phenomenon,
highly prominent in juvenile ages. Nevertheless, the adult brain
can, at some extent, dynamically reorganize its structure by
modulating synaptic connection between neurons. Fascinating,
newly born neurons are produced in specific area of the
adult CNS, and they have been involved in learning and
memory processes. Adult neurogenesis is sensitive to a
variety of environmental stimuli such as stress (Mirescu
and Gould, 2006) and, intriguingly, the gut microbiota has
been shown to be one of them. Indeed, dorsal hippocampal
neurogenesis was higher in adult GF mice compared to
control animals. Colonization of young GF mice at weaning
could not normalize the phenotype (Ogbonnaya et al., 2015),
underscoring the possibility that different neurophysiological
processes could be fine-tuned by the signals from the
intestinal microbes during specific sensitive periods, and
that adult neurogenesis could be primed by microbiome
cues early after birth. Furthermore, long-term antibiotic
administration in adult SPF mice significantly decreased
hippocampal neurogenesis, although it could be completely
restored by probiotics or voluntary exercise. An interesting
mechanistic explanation for the reduced neurogenesis upon
antimicrobial treatment is the decreased infiltration of specific
immune cells: Ly6Chi monocytes. Ly6Chi population was rescued
by probiotics and exercise and strikingly, the adoptive transfer
of Ly6Chi monocytes in animals treated with antibiotics fully
rescued hippocampal neurogenesis (Möhle et al., 2016). This
discovery sheds light on the link between immune cells,
brain plasticity and gut microbiome pointing to the immune
system as a route to transduce the commensal bacteria action
on the CNS.
The discussed evidence suggests that the intestinal microbiota
could contribute to the shaping of neural networks during
development, affecting behavior and neuronal physiology later
in life. Indeed, we might speculate that together with inborn
genetic factors and novel experience inputs, the bacteria
derived signals could act on an immature and plastic postnatal
brain substrate to fine-tune further remodeling of synaptic
connections and neuronal circuitry. However, so far no direct
evidence of an action of the gut microbiome on specific
neuronal populations function, or on the physiology of
brain circuits especially during neurodevelopment has been
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demonstrated. The bacterial ecosystem and its perturbation
are associated with certain neurochemical, structural changes
and/or behavioral outcomes, mainly analyzed in adult animals.
It is unclear if the presence, absence, or perturbation of
the microbiome community is causative and promotes the
molecular and phenotype alterations, or if the modifications are
a consequence of secondary effects. The lack of mechanistic
insights resides, at least in part, on the complexity of the
communication routes between the intestinal ecosystem and the
CNS, which integrates neuronal, hormonal and immunological
signaling. In the next section an overview of the possible
dual cross-talk pathways connecting brain and intestine will be
examined.
GI TRACT-BRAIN CROSSTALK PATHWAYS
AND THEIR RELEVANCE IN CNS
FUNCTION
Enteric Nervous System and Vagus Nerve
A well-known path is represented by the vagus nerve. The
gut microbes could directly activate the enteric nervous system
(ENS) that innervate the entire length of the microvilli (Furness,
2012), and through the vagus nerve transmit inputs to the brain.
Indeed, vagotomy prevented the anxiolytic and antidepressant
effect of a probiotic treatment (Lactobacillus Rhamnosus (JB-1))
in conventionally raised BALB/c mice, and completely inhibited
the modifications in GABAA receptor gene expression in
hippocampus and amygdala (Bravo et al., 2011). However, no
functional changes in neuronal circuits of these specific areas
were investigated, opening further questions on how the stimulus
from the probiotic administration through the vagus nerve
could be translated in the behavioral phenotype. Notably, some
of the behavioral traits affected by the intestinal commensals
are not dependent on the vagus nerve and the autonomic
nervous system. In fact, the administration of an antibiotic
cocktail was able to perturb the microbiome composition,
increase exploratory phenotype and expression of BDNF in the
hippocampus of SPF mice, and strikingly, these effects did not
rely on an intact vagal connection (Bercik et al., 2011). These
findings underlie the intricate crosstalk between intestinal flora
and CNS, suggesting multiple and mostly unexplained lines
of actions of the gut symbionts on complex behaviors and
neurophysiology.
Circulation
The intestinal epithelium regulates the passage of nutrients and
other substances into the blood stream. A variety of metabolites
and neurotransmitters are produced by the gut microorganisms,
enabling a complicate exchange of sensory information with the
host (Sharon et al., 2014). The microbes secrete vitamins, SCFA,
serotonin, GABA, acethylcoline, dopamine and noradrenaline
etc. into the gut lumen. After absorption and via the
circulatory system, some of these molecules can eventually
cross the blood-brain barrier (BBB) and reach the brain in
which they could play active functions. How these substances
can influence the physiology of neuronal circuits is still
unknown. Among the various metabolites, SCFA, the end
products of complex-polysaccharide fermentation, have been
involved in metabolic homeostasis, infection and inflammation,
host-microbiota interactions etc. (Ríos-Covián et al., 2016). They
are up-taken by glial cells and neurons in the CNS and exploited
as an energy source, especially in the developing brain (Rafiki
et al., 2003). Interestingly, butyrate and propionate act as histone
deacetylase (HDAC) inhibitor (Waldecker et al., 2008) and
they might influence gene expression and the host epigenome
through chromatin remodeling in various tissues, including the
brain.
Interaction through the Immune System
The intestinal symbionts are fundamental for the development
of the host immune system and this seems to be a key indirect
communication route between the gut microbiota and the
CNS. The gut flora produces microbial-associated molecular
patterns (MAMPS) and metabolites that can stimulate immune
cells’ function and eventually influence neurophysiology and
behavior (Mu et al., 2016). Remarkably, the gut microbiome
is crucial for the maturation of microglial cells, the tissue
resident macrophage of the brain. Depletion of the intestinal
commensal dramatically jeopardized microglia development
and function in adult mice, that maintained a more juvenile
state and decreased its responses to MMPA and pathogen
encounter. Strikingly, the administration of SCFA was able
to completely revert the impairment, indicating that signals
from the gut flora play an essential role in microglia function
maintenance (Erny et al., 2015). It is worth noting that
microglia are emerging as a key players in synaptic pruning
in the developing brain, consisting in the elimination of select
synapses to ensure a correct wiring of the neuronal network
(Paolicelli et al., 2011). Furthermore, even in absence of an
inflammatory process, microglial cells release immune-related
signaling molecules, which can impact neuronal transmission
and synaptic plasticity (Wu et al., 2015). Based on this
evidence, we could hypothesize that during neurodevelopment
the intestinal microbiota might fine-tune neuronal circuits
function and plasticity via the modulation of microglial cell
action.
Different types of signals generated by the GI tract
microbiota might directly reach the host brain or be translated
to the CNS in an indirect fashion soon after birth and
during sensitive periods for neurodevelopment. Thus, aberrant
alteration in the commensal composition (e.g., antibiotics,
mode of delivery, stress, diet) could deteriorate gut-brain
communication pathways and be partially responsible for an
abnormal shaping of host neuronal circuits and, consequently,
for the behavioral impairment occurring in neurological diseases.
CONTRIBUTION OF THE INTESTINAL
MICROBIOTA TO ALTERED
NEURODEVELOPMENTAL TRAJECTORY
New epidemiological and clinical evidence has shown
comorbidity between neurological illness and GI tract
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disturbances. For instance, a subset of autism-spectrum
disorders (ASD) patients exhibit GI symptoms, abdominal
pain, increased intestinal permeability (Valicenti-McDermott
et al., 2006; Boukthir et al., 2010; de Magistris et al., 2010;
Coury et al., 2012; Hsiao, 2014) and, intriguingly, an altered
composition of their gut microbiome (Kohane et al., 2012;
Kang et al., 2013; Wang et al., 2013), implying a possible
link between dysbiosis (an aberrant shift in microbial
ecology) and neurodevelopmental diseases. Autism is an
extremely heterogeneous neurodevelopmental disorder
and its onset can vary, with some children showing signs
from early infancy while others exhibit symptoms of
regression at the age of 2–3 years. Notably, during the
second and third year of life the microbiome is subjected
to an important evolution, becoming more similar to the
adult ecosystem (Yatsunenko et al., 2012), indicating a
further link between commensal bacteria and ASD. Autism
is characterized by stereotypical behaviors, and deficit in social
interactions and communication (Wang and Doering, 2015).
Intriguingly, GF mice displayed social skills impairment
and excessive self-grooming, considered equivalent to
repetitive behaviors in humans. Post-weaning colonization
partially reversed the phenotype, ameliorating self-grooming,
social avoidance but not social cognition (Desbonnet et al.,
2014), indicating that the window of opportunity for the
microbiota to impact brain circuits might be different for
distinct emotional/social behaviors and, eventually, sensory
modalities.
Antibiotic use during pregnancy is a common practice (Broe
et al., 2014), although little is known about their effect on the
fetus development. Perinatal antibiotic treatment in pregnant
mice disrupted the microbiome population of both mother
and offspring. Remarkably, alteration in the offspring behavior
characterized by decreased locomotor and explorative activity
was observed at 4 weeks of age, a phenotype that was completely
reverted by fostering the pups by control dams (Tochitani
et al., 2016). Similarly, periconceptional succynilsulfathiazole (a
non-absorbable antibiotic) exposure in rat dams significantly
modified the progeny’s performance in several tests. Indeed,
the offspring exhibited low social interactions, higher anxiety, a
deficit in prepulse inhibition, which are behavioral abnormalities
associated with ASD, schizophrenia and other human mental
disorders (Degroote et al., 2016). Despite the lack of mechanistic
insights, these works highlight the importance of a healthy
mother microbiota to circumvent potential abnormal behavioral
trajectories in the offspring.
As already mentioned, the dietary regimen of the mother
is an important element in the establishment of the neonates’
intestinal ecosystem. Maternal obesity has been connected to
an increase in the risk of neurodevelopmental illness and ASD
incidence in children (Krakowiak et al., 2012; Sullivan et al., 2014;
Connolly et al., 2016). A very new and insightful study in rodents
has revealed a possible mechanism. The offspring of high fat
diet fed mice displayed social deficits driven by gut microbiome
dysbiosis. In fact, the co-housing and subsequent microbiota
sharing with the offspring of lean mothers, restored the social
impairments. Notably, a single probiotic species, Lactobacillus
reuteri, could ameliorate the social skills and rescue impaired
long-term potentiation in the ventral tegmental area (Buffington
et al., 2016). Another probiotic, Bacteriodes fragilis, has been
demonstrated to be beneficial in mice showing ASD-related
symptoms and dysbiosis. In particular, B. Fragilis was able to
remodel the gut microbiome and to improve communication,
repetitive and anxiety-like behaviors in mice, however it could
not correct social abilities (Hsiao et al., 2013).
Increasing evidence supports the possibility that other
neuropsychiatric disorders of potential neurodevelopmental
origins, such as schizophrenia (Dinan et al., 2014; Sherwin
et al., 2016), bipolar disorder (Dickerson et al., 2016),
depression (Hagan et al., 2015; Mangiola et al., 2016), might
be dependent on the microbiome composition early in life.
Focusing on schizophrenia, premature birth, that is associated
with microbiota changes (Groer et al., 2014; Gibson et al., 2016),
positively correlates with schizophrenia incidence (Johnson and
Marlow, 2011; Nosarti et al., 2012). Furthermore, alteration of
the immune system (Dickerson et al., 2016) and impaired GI
functions are frequently present in psychotic patients (Severance
et al., 2016). Unfortunately, no information is available on
the fecal microbiota composition in individuals affected by
schizophrenia; nonetheless the oropharyngeal microbiome in
adult schizophrenic subjects exhibited significant differences at
the phylum and species levels with respect to non-psychiatric
controls (Castro-Nallar et al., 2015). In rodents, there are no
systematic studies investigating the role of the intestinal microbes
in schizophrenia. However, an interesting work demonstrated
that the microbiota contributes to the myelinization process
specifically in the prefrontal cortex (PFC): a brain region
involved in attention, memory, emotional learning, and critically
connected to neuronal disorders such as ASD and schizophrenia.
GF mice displayed an upregulation in the gene program
linked to myelinization, and hypermylinated axons in the PFC.
Importantly, post-weaning bacteria colonization was not able to
normalize myelin oligodendrocyte glycoprotein (MOG) levels
(Hoban et al., 2016), again pointing toward the existence
of specific critical periods for the microbiota actions on the
brain. These results reveal new avenues to better understand
the possible relationship between gut microbiome and myelin
maturation, and subsequently its impact on the onset of
psychiatric diseases linked to myelinization abnormalities.
Although the link between dysbiosis, feeding habits,
periconceptional/perinatal antibiotic use and behavioral
abnormalities in neurodevelopmental disorders has still to be
clarified, based on these studies and clinical reports (Critchfield
et al., 2011; Fond et al., 2015), probiotics, prebiotics and dietary
manipulations in early childhood may represent promising
interventions for ameliorating some autistic features and,
eventually, for preventing an increase in the incidence of ASD or
other neuropsychiatric illnesses.
FUTURE OUTLOOKS
The last two decades have been characterized by exciting
discoveries unveiling an unexpected link between intestinal
flora and brain function. PFC myelinization (Gacias et al.,
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2016; Hoban et al., 2016), behavioral responses to drugs of
abuse (i.e., cocaine; Kiraly et al., 2016), integrity of BBB
(Braniste et al., 2014), ischemic brain injury (Benakis et al.,
2016) are just few of the phenomena (see also previous
sections) that have been demonstrated to be affected by
commensal bacteria. Furthermore, the gut microbes seem
to be an environmental factor impacting brain development
possibly through metabolites or other microbiota-derived
dependent molecules, subsequently influencing behavior later
in life. The fascinating observation of a critical period in
which the microbiota could affect neurodevelopment and
the existence of sensitive periods for experience-dependent
refinement of sensory modalities (i.e., vision, hearing etc.),
language acquisition, fear extinction and many others processes,
suggests the appealing possibility of microbiome-driven stimuli
involvement in fine-tuning neuronal circuits remodeling during
early age. Although some studies have shown microbiota-
dependent modifications in brain chemistry and behaviors,
there are no specific molecular mechanisms explaining how
neurophysiology can be altered by the microbiome and how
changes in the gut commensals during critical periods of
postnatal neurodevelopment might impact neurodevelopmental
trajectories, eventually resulting in ASD and/or in other
neurological diseases. Indeed, to dissect the mechanisms
underlying the gut microbiome actions on the brain during
sensitive periods and, on the other hand, how signals
from the CNS can shape the microbiome ecosystem, will
reveal new avenues of future directions to apply microbiota-
based therapeutics for the treatment of neurodevelopmental,
psychiatric and in general neurological disorders, highly
pervasive illness in the modern society.
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